SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-24-002746
Filing Date
2024-05-10
Accepted
2024-05-10 11:27:20
Documents
44
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20240331_10q.htm   iXBRL 10-Q 554705
2 EXHIBIT 31.1 ex_665418.htm EX-31.1 10414
3 EXHIBIT 31.2 ex_665419.htm EX-31.2 12424
4 EXHIBIT 32.1 ex_665420.htm EX-32.1 8191
  Complete submission text file 0001171843-24-002746.txt   2955097

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20240331.xsd EX-101.SCH 25729
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20240331_def.xml EX-101.DEF 195164
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20240331_lab.xml EX-101.LAB 194148
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20240331_pre.xml EX-101.PRE 214118
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20240331_cal.xml EX-101.CAL 23930
48 EXTRACTED XBRL INSTANCE DOCUMENT xbit20240331_10q_htm.xml XML 297425
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 24933516
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)